Lori Kiefer
Biographic Data
| ID | 5411210 |
|---|---|
| NAME | Lori Kiefer |
| GIVEN NAMES | Lori |
| FAMILY NAME | Kiefer |
| SIGNATURE | KIEFER L |
| AFFILIATIONS | University of Toronto |
| ORCID | 0000-0001-8190-2118 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 6 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 1 |
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities
People with opioid use disorders are overrepresented in correctional facilities, and are at high risk of opioid overdose. Despite the fact that buprenorphine/naloxone is the first line treatment for people with opioid use disorder, there are often institutional, clinical, and logistical barriers to buprenorphine/naloxone initiation in correctional facilities. Guided by the knowledge-to-action framework, this knowledge translation project focused …
For Everyone
We examined HIV care and treatment in prison and after release for people with HIV in Ontario, Canada, and compared HIV care and treatment with the general population. We used administrative data to identify people with HIV released from provincial prison in 2010 and in the general population. We calculated the proportion of people with HIV who accessed HIV care in prison. We compared HIV care use between people with HIV on prison release and in …
A comparison of the observed and expected prevalence of HIV in persons released from Ontario provincial prisons in 2010
A Systematic Review of Randomized Controlled Trials of Interventions to Improve the Health of Persons During Imprisonment and in the Year After Release
We systematically reviewed randomized controlled trials of interventions to improve the health of people during imprisonment or in the year after release. We searched 14 biomedical and social science databases in 2014, and identified 95 studies. Most studies involved only men or a majority of men (70/83 studies in which gender was specified); only 16 studies focused on adolescents. Most studies were conducted in the United States (n = 57). The ri…
Drug use prior to incarceration and associated socio-behavioural factors among males in a provincial correctional facility in Ontario, Canada
Prevalence and Predictors of Urethral Chlamydia and Gonorrhea Infection in Male Inmates in an Ontario Correctional Facility
Prevalence and Predictors of Urethral Chlamydia and Gonorrhea Infection in Male Inmates in an Ontario Correctional Facility
Drug use prior to incarceration and associated socio-behavioural factors among males in a provincial correctional facility in Ontario, Canada
A Systematic Review of Randomized Controlled Trials of Interventions to Improve the Health of Persons During Imprisonment and in the Year After Release
We systematically reviewed randomized controlled trials of interventions to improve the health of people during imprisonment or in the year after release. We searched 14 biomedical and social science databases in 2014, and identified 95 studies. Most studies involved only men or a majority of men (70/83 studies in which gender was specified); only 16 studies focused on adolescents. Most studies were conducted in the United States (n = 57). The ri…
A comparison of the observed and expected prevalence of HIV in persons released from Ontario provincial prisons in 2010
For Everyone
We examined HIV care and treatment in prison and after release for people with HIV in Ontario, Canada, and compared HIV care and treatment with the general population. We used administrative data to identify people with HIV released from provincial prison in 2010 and in the general population. We calculated the proportion of people with HIV who accessed HIV care in prison. We compared HIV care use between people with HIV on prison release and in …
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities
People with opioid use disorders are overrepresented in correctional facilities, and are at high risk of opioid overdose. Despite the fact that buprenorphine/naloxone is the first line treatment for people with opioid use disorder, there are often institutional, clinical, and logistical barriers to buprenorphine/naloxone initiation in correctional facilities. Guided by the knowledge-to-action framework, this knowledge translation project focused …
Medicine (5 works) · Criminology (3 works) · Demography (3 works) · Demography (3 works) · Environmental health (3 works) · Homelessness and Social Issues (3 works) · Psychiatry (3 works) · Psychology (3 works) · Sociology (3 works) · Criminal Justice and Corrections Analysis (2 works)